Login to your account

Username *
Password *
Remember Me
RCT supports the use of therapeutic heparin in moderately ill patients admitted to the hospital with Covid-19.

RCT supports the use of therapeutic heparin in moderately ill patients admitted to the hospital with Covid-19.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial – The BMJ Commentary: High-dose of readily available blood thinner reduces risk of death for moderately ill COVID-19 patients – St. Michael’s Hospital Related studies (some […]

The post RCT supports the use of therapeutic heparin in moderately ill patients admitted to the hospital with Covid-19. appeared first on Links Medicus.

Lu 518 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.